Atypical Oral Presentation of SARS-CoV-2 Infection: Case Report

Hypogeusia, dysgeusia and ageusia are commonly prevalent and considered as the first recognized oral symptom of SARS-CoV-2 infection. Various other oral manifestations have also been reported in patients positive for SARS-CoV-2 infection. This article presents clinical presentation of oral lesions in two patients who were subsequently confirmed with SARS-CoV-2 infection.

Oral Health in Adult Patients Receiving Palliative Care: A Mixed Method Study

Oral disease is highly prevalent in persons receiving palliative care (PRPC). Yet, little is known about how PRPC perceive their oral health status and related treatment needs. Forty-nine PRPC were recruited. They first completed a structured oral symptom review, followed by an oral exam. A nested sample of 11 participants also completed an in-depth interview querying their perceived oral health concerns and related treatment needs. Quantitative and qualitative data was analyzed and integrated for interpretation. Eighty-six percent of participants reported at least one oral symptom, including dry mouth (83.7%), a pain-related symptom (40.8%), or oral function difficulties (51.0%). About 40% of participants reported compromised quality of life due to oral conditions; however, the perceived impacts and treatment needs were modest. Oral disease was highly prevalent in PRPC, yet its overall impact was modest. Except for painful symptoms, most participants reported limited desire to seek treatment for oral health conditions.

A REVIEW OF ANALYTICAL METHODS FOR DETERMINATION OF TYPE- II ANTIDIABETIC DRUGS IN PHARMACEUTICALS AND BIOLOGICAL MATRICES

Its a meglitinide analog is an oral symptom designed to common hour aldohexose excursions. Through not an antidiabetic, it acts in AN analogous manner by binding to antidiabetic receptor likewise on alternative one distinct receptor-» closure of adenosine triphosphate dependent K+ channel-» of depolarization-» internal secretion unharnesses. Repaglinide induces fast onset short-lasting internal secretion discharged. It is administered antero every main meal to stabilize postprandial hyperglycemia; the dose ought to be emitted if a food material is incomprehensible. Because of less permanent action, it perhaps had a lower risk of the seriousness of hypoglycemia. Repaglinide is indicated solely in type-II DM as another to sulfonylureas, or to supplement metformin/long internal secretion. It ought to be avoided in disease. This review delivers a detail description totally different of various analytical ways were printed for the estimation of repaglinide and its combination medicine in prescription drugs and biological matrices. This assessment encompasses different analytical ways such as chemical analysis ways, aggressive liquid activity (HPLC), superior thin-layer activity (HPTLC), liquid chromatography-mass spectroscopic analysis (LC-MS), and ultra-performance liquid activity (UPLC), GC-MS, [LC-ESI-MS-MS], capillary activity (CE), titrimetric and chemical science technique, and designation study for the estimation of repaglinide and together with a mixture.